ReviewFrontiers in pharmacology2026

Targeting pancreatic cancer with natural compounds: molecular mechanisms, preclinical evidence, clinical perspectives, and limitations.

Alberto Orta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.